Clinical Trial 42354

Chiefland, FL 32626


A phase 3 multi-center, randomized, double-blind, placebo-controlled, clinical study to assess the efficacy and safety of linzagolix in subjects with moderate to severe endometriosis-associated pain.

Qualified Participants Must:

• 18-49 years of age
• Diagnosed up to 10 years before screening
• BMI greater than 17 Has not had a hysterectomy
• Has not had bilateral oophorectomy
• Has not had any major abdominal surgery

Qualified Participants May Receive:

High Quality Medical Care

Study Medication

$100.00 per visit for up to 16 visits

DXA Scan

Mammogram if >12 months since last screening

Transvaginal Ultrasound if required

Lab work

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.